[Platelet function after the single administration of buflomedil].

Area of Science:

• Pharmacology
• Hematology
• Cardiovascular Medicine

Context:

• Buflomedil is a clinically used drug for peripheral vascular disease.
• Previous studies indicated buflomedil's inhibitory effect on platelet aggregation.

Purpose:

• To investigate the specific effects of buflomedil on platelet function in healthy volunteers.

Summary:

• Healthy volunteers received a single 300 mg oral dose of buflomedil.
• Ex vivo testing confirmed buflomedil's inhibition of ADP-induced platelet aggregation.
• Buflomedil did not affect plasma thromboxane B2, platelet proteins, prostaglandin sensitivity, or prostacyclin synthesis.

Impact:

• This study validates buflomedil's antiplatelet activity.
• The findings support buflomedil's therapeutic use in conditions involving platelet hyperaggregation.